Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 3/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.33 |
| ▸ | FLT3 | P36888 | 2/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | PAK4 | O96013 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12761337 | 1.00 | JAK2 (0.33) | JAK2FGFR1FLT3CLK4LMNA | |
| SCHEMBL12743233 | 0.94 | MEN1 (0.39) | FLT3CLK4LMNAPRKD3MAP4K4 | |
| SCHEMBL16489400 | 0.81 | PRNP (0.39) | FLT3CLK4PRKD3MAP4K4CSF1R | |
| SCHEMBL12761336 | 0.80 | CYP2A6 (0.47) | CYP2A6ESR2ALDH1A1MEN1KMT2A | |
| SCHEMBL12796536 | 0.79 | PDK2 (0.34) | — | |
| SCHEMBL16489389 | 0.78 | KCNQ3 (0.36) | GSK3BHPGDCYP2A6ALDH1A1MEN1 | |
| SCHEMBL16558522 | 0.78 | LPL (0.37) | CSF1R | |
| SCHEMBL16489393 | 0.76 | CYP2A6 (0.43) | CYP2A6ESR2GPR84MEN1KMT2A | |
| SCHEMBL15203046 | 0.76 | NT5E (0.43) | JAK2FGFR1FLT3CLK4METAP2 | |
| SCHEMBL14092890 | 0.74 | CYP2A6 (0.41) | LMNAPTGDR2CYP2A6ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | NQO1, NDUFS2, NDUFS5 | JAK2 2292/4885FGFR1 1784/4885FLT3 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.